The scientist behind the BioNTech-Pfizer vaccine has said he is confident that his candidate will work against the new variant of coronavirus detected in the UK. Professor Ugur Sahin, chief executive of BioNTech, said further studies were being conducted to assess whether the vaccine induces full protection against the new variant. Read More“Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variants,” Prof Sahin told a news conference the day after the two-dose candidate was approved for use in the EU. Prof Sahin said it would take “about two weeks” to test his candidate against the variant. “We have already tested the vaccine against around 20 other virus variants with other mutations,” he said.

Source: Irish Independent December 23, 2020 02:35 UTC